Pluto Biosciences has filed a notice of an exempt offering of securities to raise $3,704,373.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, Pluto Biosciences is raising $3,704,373.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Rani Powers played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About Pluto Biosciences
Pluto is a cloud-based platform empowering life sciences researchers to visualize and analyze complex biological data sets easily, with no coding required. Upload raw data from a wide variety of experiment types (qPCR, ELISA, RNA-seq, metabolomics, proteomics, and more), generate interactive results pages, and share them easily and securely with collaborators.
To learn more about Pluto Biosciences, visit http://pluto.bio/
Contact:
Rani Powers, Chief Executive Officer
719-247-0726
https://www.linkedin.com/in/rani-powers/
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.